News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
257,400 Results
Type
Article (36896)
Company Profile (18)
Press Release (220486)
Multimedia
Podcasts (4)
Webinars (9)
Section
Business (71276)
Career Advice (456)
Deals (7074)
Drug Delivery (13)
Drug Development (32161)
Employer Resources (39)
FDA (6506)
Job Trends (5087)
News (116067)
Policy (8537)
Tag
2024 Biotech Bay Standard (2)
2024 Genetown Standard (1)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioCapital Standard (1)
2026 Biotech Bay Standard (1)
Academia (2612)
Academic (1)
Accelerated approval (2)
Adcomms (7)
Allergies (28)
Alliances (17230)
ALS (37)
Alzheimer's disease (610)
Antibody-drug conjugate (ADC) (19)
Approvals (6534)
Artificial intelligence (72)
Autoimmune disease (2)
Automation (4)
Bankruptcy (41)
Best Places to Work (4396)
BIOSECURE Act (3)
Biosimilars (16)
Biotechnology (15)
Bladder cancer (20)
Brain cancer (9)
Breast cancer (102)
Cancer (733)
Cardiovascular disease (82)
Career advice (421)
Career pathing (9)
CAR-T (47)
Cell therapy (133)
Cervical cancer (7)
Clinical research (25354)
Collaboration (210)
Compensation (9)
Complete response letters (2)
COVID-19 (1821)
CRISPR (14)
C-suite (147)
Cystic fibrosis (31)
Data (908)
Decentralized trials (1)
Denatured (3)
Depression (11)
Diabetes (77)
Diagnostics (2747)
Digital health (6)
Diversity (5)
Diversity, equity & inclusion (14)
Drug discovery (27)
Drug pricing (19)
Drug shortages (2)
Duchenne muscular dystrophy (26)
Earnings (14439)
Editorial (5)
Employer branding (3)
Employer resources (36)
Events (26653)
Executive appointments (482)
FDA (6906)
Featured Employer (6)
Frontotemporal dementia (4)
Funding (251)
Gene editing (39)
Generative AI (7)
Gene therapy (103)
GLP-1 (169)
Government (1815)
Guidances (10)
Healthcare (9000)
Huntington's disease (4)
IgA nephropathy (7)
Immunology and inflammation (16)
Indications (9)
Infectious disease (1892)
Inflammatory bowel disease (51)
Inflation Reduction Act (2)
Influenza (27)
Intellectual property (18)
Interviews (46)
IPO (2999)
IRA (7)
Job creations (807)
Job search strategy (395)
Kidney cancer (4)
Labor market (5)
Layoffs (55)
Leadership (2)
Legal (1338)
Liver cancer (28)
Lung cancer (102)
Lymphoma (55)
Machine learning (1)
Management (12)
Manufacturing (51)
MASH (23)
Medical device (6044)
Medtech (6045)
Mergers & acquisitions (4170)
Metabolic disorders (160)
Multiple sclerosis (28)
NASH (5)
Neurodegenerative disease (28)
Neuropsychiatric disorders (1)
Neuroscience (771)
NextGen: Class of 2025 (3043)
Non-profit (2547)
Northern California (756)
Now hiring (3)
Obesity (61)
Opinion (42)
Ovarian cancer (32)
Pain (19)
Pancreatic cancer (28)
Parkinson's disease (42)
Partnered (4)
Patents (52)
Patient recruitment (50)
Peanut (18)
People (35282)
Pharmaceutical (2)
Pharmacy benefit managers (1)
Phase I (7564)
Phase II (11339)
Phase III (8434)
Pipeline (285)
Policy (22)
Postmarket research (1365)
Preclinical (3519)
Press Release (26)
Prostate cancer (31)
Psychedelics (8)
Radiopharmaceuticals (87)
Rare diseases (119)
Real estate (1844)
Recruiting (17)
Regulatory (6086)
Reports (8)
Research institute (1663)
Resumes & cover letters (33)
Rett syndrome (3)
RNA editing (1)
RSV (25)
Schizophrenia (14)
Series A (38)
Series B (27)
Service/supplier (1)
Sickle cell disease (27)
Southern California (603)
Spinal muscular atrophy (54)
Sponsored (8)
Startups (1421)
Stomach cancer (2)
Supply chain (6)
Tariffs (1)
The Weekly (1)
United States (6665)
Vaccines (337)
Venture capitalists (1)
Weight loss (30)
Women's health (6)
Worklife (3)
Date
Today (1)
Last 7 days (144)
Last 30 days (717)
Last 365 days (10112)
2025 (2716)
2024 (10854)
2023 (13359)
2022 (20673)
2021 (22362)
2020 (22040)
2019 (19069)
2018 (14229)
2017 (12359)
2016 (12417)
2015 (14176)
2014 (10728)
2013 (10163)
2012 (10391)
2011 (10646)
2010 (9544)
Location
Africa (344)
Alabama (15)
Alaska (3)
Arizona (68)
Arkansas (9)
Asia (15531)
Australia (3286)
California (1625)
Canada (558)
China (136)
Colorado (95)
Connecticut (79)
Delaware (41)
Europe (36745)
Florida (292)
Georgia (75)
Idaho (20)
Illinois (220)
India (7)
Indiana (92)
Iowa (2)
Japan (54)
Kansas (23)
Kentucky (13)
Louisiana (4)
Maine (17)
Maryland (233)
Massachusetts (1101)
Michigan (55)
Minnesota (115)
Mississippi (1)
Missouri (31)
Montana (16)
Nebraska (7)
Nevada (18)
New Hampshire (22)
New Jersey (568)
New Mexico (16)
New York (498)
North Carolina (402)
North Dakota (3)
Northern California (756)
Ohio (79)
Oklahoma (5)
Oregon (11)
Pennsylvania (365)
Puerto Rico (1)
Rhode Island (11)
South America (445)
South Carolina (11)
Southern California (603)
Tennessee (68)
Texas (267)
Utah (53)
Virginia (46)
Washington D.C. (19)
Washington State (161)
West Virginia (2)
Wisconsin (14)
257,400 Results for "georgetown university hospital".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors
KeifeRx announced entry into an amended exclusive licensing agreement with Georgetown University to advance the development of novel tyrosine kinase inhibitor chemical entities for the treatment of multiple disease indications.
January 8, 2024
·
3 min read
Press Releases
University Hospitals Cleveland Medical Center Activates AI for Early Lung Cancer Identification
April 2, 2025
·
4 min read
Press Releases
University Medical Centre Ljubljana and University Hospital of Maribor Elevate Antimicrobial Stewardship with DoseMeRx
January 15, 2025
·
3 min read
Press Releases
Novotech Partners with Kyungpook National University Hospital to Strengthen Clinical Trial Capabilities in South Korea
March 19, 2025
·
4 min read
BioMidwest
Cantex Pharmaceuticals Obtains Exclusive Worldwide Rights to Intellectual Property From Georgetown University for Azeliragon as a Potential Treatment of Cancer-Related Cognitive Decline
Cantex Pharmaceuticals, Inc. announced that it has obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer-treatment related cognitive decline.
June 1, 2023
·
4 min read
Press Releases
Quest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
January 27, 2025
·
2 min read
Bio NC
vTv Therapeutics Partner Cantex Pharmaceuticals Licenses Exclusive Rights to Intellectual Property from Georgetown University for Azeliragon as a Potential Treatment for Cancer-Related Cognitive Decline
vTv Therapeutics Inc. announced that Cantex Pharmaceuticals, Inc. recently obtained an exclusive worldwide license from Georgetown University for intellectual property related to the potential use of azeliragon to treat, prevent or alleviate cancer treatment-related cognitive decline.
June 16, 2023
·
5 min read
BioCapital
Shuttle Pharmaceuticals Enters Research Agreement with Georgetown University for Testing of Small Molecule Radiation Sensitizers and Immune Activation Candidates
Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) today announced it has entered a research agreement with Georgetown University focused on the evaluation of the Company’s lead HDAC6 inhibitor candidate, SP-2-225, evaluating the anti-tumor effect of the combination of SP-2-225 and RT in a syngeneic breast cancer model.
March 22, 2023
·
4 min read
Press Releases
Calidi Biotherapeutics Announces Commencement of Recruitment for Multiple Dose CLD-101 Trial in Patients with Newly Diagnosed High Grade Glioma at Northwestern University Hospital
February 24, 2025
·
5 min read
BioMidwest
Heidelberg University Hospital in Germany Invests in Fourth Accuray Radiotherapy Device, the Radixact® System, to Improve Cancer Patient Care
Accuray Incorporated announced that long-term customer Heidelberg University Hospital in Heidelberg, Germany, has selected the company’s Radixact® System, equipped with its proprietary ClearRT®, Synchrony® and VOLO™ Ultra Optimizer solutions, to help transform their approach to cancer care.
June 27, 2024
·
5 min read
1 of 25,740
Next
